RILUZOLE Side Effects

6957603-X | Pemphigoid
on Aug 18, 2010 Female patient from JAPAN , 61 years of age, weighting 109.5 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Riluzole (View Usage). Patient experienced the following unwanted or unexpected effects: pemphigoid. Riluzole dosage: . During the same period patient was treated with METHYCOBAL (View Methycobal Review and Methycobal Label ). Patient was hospitalized.

6957599-0 | Condition Aggravated, Pemphigoid, Respiratory Failure
Patient was taking Riluzole (View Usage). Patient had the following side effects: condition aggravated, pemphigoid, respiratory failure on Aug 18, 2010 from JAPAN Additional patient health information: Male patient , 76 years of age, weighting 105.8 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), upper respiratory tract inflammation and. Riluzole dosage: . During the same period patient was treated with AMBROXOL (View Ambroxol Review and Ambroxol Label ), CELTECT (View Celtect Review and Celtect Label ), METHYCOBAL (View Methycobal Review and Methycobal Label ), ASTOMIN (View Astomin Review and Astomin Label ). Patient was hospitalized.

6936305-X | Condition Aggravated, Disease Progression
Adverse event was reported on Aug 16, 2010 by a Female patient taking Riluzole (View Usage) (Dosage: ) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Location: JAPAN , 38 years of age, After Riluzole was administered, patient had the following side effects: condition aggravated, disease progression.

6711319-3 | Disease Progression
on Apr 30, 2010 Male patient from AUSTRALIA , 77 years of age, was diagnosed with motor neurone disease and was treated with Riluzole (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression. Riluzole dosage: .


6692267-4 | Disease Progression
on Apr 21, 2010 Male patient from AUSTRALIA , 77 years of age, was diagnosed with motor neurone disease and was treated with Riluzole (View Usage). Patient had the following side effects: disease progression. Riluzole dosage: .

6575094-8 |
Patient was taking Riluzole (View Usage). on Feb 01, 2010 from CANADA Additional patient health information: Male patient , 63 years of age, . Riluzole dosage: .

6571843-3 | Pemphigoid
Adverse event was reported on Nov 24, 2009 by a Female patient taking Riluzole (View Usage) (Dosage: ) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Location: JAPAN , 61 years of age, weighting 109.5 lb, Patient experienced the following unwanted or unexpected effects: pemphigoid. During the same period patient was treated with METHYCOBAL (View Methycobal Review and Methycobal Label ). Patient was hospitalized.

6571820-2 | Condition Aggravated, Pemphigoid, Respiratory Failure
on Nov 24, 2009 Male patient from JAPAN , 76 years of age, weighting 105.8 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), upper respiratory tract inflammation and was treated with Riluzole (View Usage). Patient had the following side effects: condition aggravated, pemphigoid, respiratory failure. Riluzole dosage: . During the same period patient was treated with AMBROXOL (View Ambroxol Review and Ambroxol Label ), CELTECT (View Celtect Review and Celtect Label ), METHYCOBAL (View Methycobal Review and Methycobal Label ), ASTOMIN (View Astomin Review and Astomin Label ). Patient was hospitalized.

6571804-4 | Condition Aggravated, Disease Progression
on Oct 01, 2009 Female patient from JAPAN , 38 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Riluzole (View Usage). After Riluzole was administered, patient had the following side effects: condition aggravated, disease progression. Riluzole dosage: .

6535014-9 | Unresponsive To Stimuli
Patient was taking Riluzole (View Usage). Patient experienced the following unwanted or unexpected effects: unresponsive to stimuli on Jan 11, 2010 from UNITED STATES Additional patient health information: Male patient , 47 years of age, weighting 176.0 lb, was diagnosed with malignant melanoma, metastases to central nervous system and. Riluzole dosage: 50 Mg Bid Po.

6477409-8 | Pemphigoid
Adverse event was reported on Nov 24, 2009 by a Female patient taking Riluzole (View Usage) (Dosage: ) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Location: JAPAN , 61 years of age, weighting 109.5 lb, Patient had the following side effects: pemphigoid. During the same period patient was treated with METHYCOBAL (View Methycobal Review and Methycobal Label ). Patient was hospitalized.

6477408-6 | Condition Aggravated, Pemphigoid, Respiratory Failure
on Nov 24, 2009 Male patient from JAPAN , 76 years of age, weighting 105.8 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), upper respiratory tract inflammation and was treated with Riluzole (View Usage). After Riluzole was administered, patient had the following side effects: condition aggravated, pemphigoid, respiratory failure. Riluzole dosage: . During the same period patient was treated with AMBROXOL (View Ambroxol Review and Ambroxol Label ), CELTECT (View Celtect Review and Celtect Label ), METHYCOBAL (View Methycobal Review and Methycobal Label ), ASTOMIN (View Astomin Review and Astomin Label ). Patient was hospitalized.

6441829-8 | Condition Aggravated, Pemphigoid, Respiratory Failure
on Nov 11, 2009 Male patient from JAPAN , 76 years of age, weighting 105.8 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), upper respiratory tract inflammation and was treated with Riluzole (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, pemphigoid, respiratory failure. Riluzole dosage: . During the same period patient was treated with AMBROXOL (View Ambroxol Review and Ambroxol Label ), CELTECT (View Celtect Review and Celtect Label ), METHYCOBAL (View Methycobal Review and Methycobal Label ), ASTOMIN (View Astomin Review and Astomin Label ). Patient was hospitalized.

6216447-7 | Accidental Exposure, Cardio-respiratory Arrest, Coma
Patient was taking Riluzole (View Usage). Patient had the following side effects: accidental exposure, cardio-respiratory arrest, coma on May 27, 2009 from Additional patient health information: Female patient , 91 years of age, was diagnosed with accidental exposure and. Riluzole dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), DISCOTRINE (View Discotrine Review and Discotrine Label ), SERESTA (View Seresta Review and Seresta Label ), MOTILIUM (View Motilium Review and Motilium Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), LOVENOX (View Lovenox Review and Lovenox Label ), LANTUS (View Lantus Review and Lantus Label ).

6163233-2 | Anorexia, Bacteria Stool Identified, Clostridium Difficile Toxin Test Positive
Adverse event was reported on Apr 20, 2009 by a Male patient taking Riluzole (View Usage) (Dosage: 1 Tab Bid Po) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Location: UNITED STATES , 66 years of age, weighting 153.0 lb, After Riluzole was administered, patient had the following side effects: anorexia, bacteria stool identified, clostridium difficile toxin test positive. Patient was hospitalized.

6043536-2 | Pancreatitis
on Jan 14, 2009 Female patient from UNITED STATES , weighting 89.07 lb, was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and was treated with Riluzole (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis. Riluzole dosage: 50mg Every 12 Hours Po. Patient was hospitalized.

5968464-X | Pulmonary Embolism
on Nov 21, 2008 Male patient from UNITED STATES , 55 years of age, weighting 162.0 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Riluzole (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Riluzole dosage: 50mg Bid Po. Patient was hospitalized.

5879590-8 | Respiratory Disorder
Patient was taking Riluzole (View Usage). After Riluzole was administered, patient had the following side effects: respiratory disorder on Sep 02, 2008 from CANADA Additional patient health information: Female patient , 51 years of age, . Riluzole dosage: Dose: Unk.

5802162-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Atrial Fibrillation, Blood Alkaline Phosphatase Increased, Disease Progression, Hypersensitivity, Lung Infiltration, Lymphadenopathy, Marrow Hyperplasia
Adverse event was reported on Jun 30, 2008 by a Male patient taking Riluzole (View Usage) (Dosage: ) . Location: UNITED STATES , 50 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial fibrillation (What is atrial fibrillation?), blood alkaline phosphatase increased, disease progression, hypersensitivity, lung infiltration, lymphadenopathy, marrow hyperplasia. During the same period patient was treated with ZOLPIDEM (Dose: Unk) (View Zolpidem Review and Zolpidem Label ).

5623974-X | Gastrostomy Tube Insertion
on Feb 08, 2008 Female patient from UNITED STATES , weighting 22.27 lb, was diagnosed with spinal muscular atrophy (What is spinal muscular atrophy?) and was treated with Riluzole (View Usage). Patient had the following side effects: gastrostomy tube insertion. Riluzole dosage: 25mg Twice Aday Po. During the same period patient was treated with TYLENOL SUSPENSION (View Tylenol Suspension Review and Tylenol Suspension Label ), GLYCOLAX (View Glycolax Review and Glycolax Label ). Patient was hospitalized.

5507537-2 | Tardive Dyskinesia
on Nov 05, 2007 Female patient from UNITED STATES , weighting 178.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), depression (What is depression?) and was treated with Riluzole (View Usage). After Riluzole was administered, patient had the following side effects: tardive dyskinesia. Riluzole dosage: 50 Mg Twice Daily Po.

5505010-9 | Pancreatitis
Patient was taking Riluzole (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis on Oct 31, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 172.0 lb, was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and. Riluzole dosage: 60 Mg Every 12 Hours 47. During the same period patient was treated with CLOMIPRAMINE HCL (View Clomipramine Hcl Review and Clomipramine Hcl Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ). Patient was hospitalized.

5401245-4 | Abdominal Pain, Back Pain, Faeces Pale, Flatulence, Pathological Fracture
Adverse event was reported on Jul 16, 2007 by a Male patient taking Riluzole (View Usage) (Dosage: Dose: 2-0-2) was diagnosed with multiple system atrophy, nausea (What is nausea?), hypertension and. Location: GERMANY , 74 years of age, weighting 163.1 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), back pain (What is back pain?), faeces pale, flatulence, pathological fracture. During the same period patient was treated with MADOPAR /00349201/ (View Madopar /00349201/ Review and Madopar /00349201/ Label ), DOMPERIDON (View Domperidon Review and Domperidon Label ), DIGITOXIN TAB (View Digitoxin Tab Review and Digitoxin Tab Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5401244-2 | Cardiovascular Disorder, Pneumonia, Pulmonary Oedema, Respiratory Failure
on Jul 16, 2007 Male patient from GERMANY , weighting 198.4 lb, was diagnosed with multiple system atrophy, hypertension and was treated with Riluzole (View Usage). After Riluzole was administered, patient had the following side effects: cardiovascular disorder, pneumonia (What is pneumonia?), pulmonary oedema, respiratory failure. Riluzole dosage: . During the same period patient was treated with DRIDASE (Dose Quantity: 0.5) (View Dridase Review and Dridase Label ), ASTONIN H (Dose Quantity: 5) (View Astonin H Review and Astonin H Label ), CARNIGEN FORTE (Dose Quantity: 2) (View Carnigen Forte Review and Carnigen Forte Label ). Patient was hospitalized and became disabled.

5401242-9 | Deep Vein Thrombosis, Hypotension, Pulmonary Embolism
on Jul 16, 2007 Male patient from GERMANY , weighting 198.4 lb, was diagnosed with multiple system atrophy and was treated with Riluzole (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), hypotension, pulmonary embolism (What is pulmonary embolism?). Riluzole dosage: . During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), BROMOCRIPTINE MESYLATE (View Bromocriptine Mesylate Review and Bromocriptine Mesylate Label ). Patient was hospitalized.

5401240-5 | Altered State Of Consciousness, Chills, Convulsion, Loss Of Consciousness, Oculogyric Crisis, Visual Acuity Reduced
Patient was taking Riluzole (View Usage). Patient had the following side effects: altered state of consciousness, chills, convulsion, loss of consciousness, oculogyric crisis, visual acuity reduced on Jul 16, 2007 from GERMANY Additional patient health information: Female patient , weighting 105.8 lb, was diagnosed with multiple system atrophy and. Riluzole dosage: . During the same period patient was treated with PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ).

5290162-9 | Alveolitis Allergic, Blood Lactate Dehydrogenase Increased, Interstitial Lung Disease, No Therapeutic Response, Pulmonary Fibrosis, Restrictive Pulmonary Disease
Adverse event was reported on Mar 14, 2007 by a Male patient taking Riluzole (View Usage) (Dosage: 50 Mg 2x/day) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Location: BELGIUM , 69 years of age, After Riluzole was administered, patient had the following side effects: alveolitis allergic, blood lactate dehydrogenase increased, interstitial lung disease, no therapeutic response, pulmonary fibrosis (What is pulmonary fibrosis?), restrictive pulmonary disease. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

5278512-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Atrial Fibrillation, Blood Alkaline Phosphatase Increased, Lymphadenopathy, Marrow Hyperplasia, Nausea, Pericarditis Constrictive
on Mar 07, 2007 Male patient from UNITED STATES , 50 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Riluzole (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial fibrillation (What is atrial fibrillation?), blood alkaline phosphatase increased, lymphadenopathy, marrow hyperplasia, nausea (What is nausea?), pericarditis constrictive. Riluzole dosage: 50 Mg Bid Unk. During the same period patient was treated with ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

5228519-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Atrial Fibrillation, Blood Alkaline Phosphatase Increased, Hypersensitivity, Lung Infiltration, Lymphadenopathy, Marrow Hyperplasia, Myalgia
on Jan 24, 2007 Male patient from UNITED STATES , 50 years of age, was treated with Riluzole (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial fibrillation (What is atrial fibrillation?), blood alkaline phosphatase increased, hypersensitivity, lung infiltration, lymphadenopathy, marrow hyperplasia, myalgia. Riluzole dosage: . During the same period patient was treated with ZOLPIDEM TARTRATE (Dose: Unk) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ).

5069903-1 | Agitation, Anterograde Amnesia, Attention Deficit/hyperactivity Disorder, Balance Disorder, Cognitive Disorder, Condition Aggravated, Disorientation, Dysarthria, Electroencephalogram Abnormal
Patient was taking Riluzole (View Usage). After Riluzole was administered, patient had the following side effects: agitation, anterograde amnesia, attention deficit/hyperactivity disorder, balance disorder, cognitive disorder, condition aggravated, disorientation, dysarthria, electroencephalogram abnormal on Jul 12, 2006 from NETHERLANDS Additional patient health information: Female patient , 44 years of age, was diagnosed with huntington's chorea and. Riluzole dosage: 50 Mg Bid Po. Patient was hospitalized.

4903679-0 | Asthenia, Blood Bicarbonate Increased, Blood Fibrinogen Increased, Blood Immunoglobulin A Increased, Blood Immunoglobulin E Increased, Blood Immunoglobulin G Increased, Blood Ph Increased, Cough
Adverse event was reported on Jan 26, 2006 by a Male patient taking Riluzole (View Usage) (Dosage: ) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Location: SPAIN , 74 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, blood bicarbonate increased, blood fibrinogen increased, blood immunoglobulin a increased, blood immunoglobulin e increased, blood immunoglobulin g increased, blood ph increased, cough. Patient was hospitalized.

4822541-5 | Corneal Infiltrates, Herpes Ophthalmic, Keratitis Bacterial, Lymphopenia, Ocular Hyperaemia, Staphylococcal Infection, Ulcerative Keratitis, Visual Acuity Reduced
on Jan 04, 2002 Female patient from SWITZERLAND , weighting 158.7 lb, was diagnosed with huntington's chorea and was treated with Riluzole (View Usage). Patient had the following side effects: corneal infiltrates, herpes ophthalmic, keratitis bacterial, lymphopenia, ocular hyperaemia, staphylococcal infection (What is staphylococcal infection?), ulcerative keratitis, visual acuity reduced. Riluzole dosage: . Patient was hospitalized.

4822540-3 | Abdominal Pain, Constipation
on May 17, 2001 Female patient from AUSTRIA , weighting 116.8 lb, was diagnosed with huntington's chorea, depression (What is depression?), hypotension, thrombosis prophylaxis and was treated with Riluzole (View Usage). After Riluzole was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), constipation (What is constipation?). Riluzole dosage: . During the same period patient was treated with REMERON (View Remeron Review and Remeron Label ), AGILAN (View Agilan Review and Agilan Label ), SANDOPARIN (View Sandoparin Review and Sandoparin Label ). Patient was hospitalized.

4822539-7 | Loss Of Consciousness, Ventricular Fibrillation
Patient was taking Riluzole (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, ventricular fibrillation on Feb 21, 2005 from GERMANY Additional patient health information: Female patient , 48 years of age, was diagnosed with huntington's chorea, hyperkinesia, sleep disorder (What is sleep disorder?) and. Riluzole dosage: . During the same period patient was treated with L THYROXIN (View L-thyroxin Review and L-thyroxin Label ), TIAPRID (View Tiaprid Review and Tiaprid Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ).

4822538-5 | Depression, Suicidal Ideation
Adverse event was reported on Jun 07, 2002 by a Female patient taking Riluzole (View Usage) (Dosage: ) was diagnosed with huntington's chorea, depression (What is depression?) and. Location: GERMANY , weighting 156.5 lb, Patient had the following side effects: depression (What is depression?), suicidal ideation. During the same period patient was treated with EFFORTIL PLUS (View Effortil Plus Review and Effortil Plus Label ), ANTACID TAB (View Antacid Tab Review and Antacid Tab Label ), FLUOXETINE HCL (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ). Patient was hospitalized.

4822537-3 | Breast Cancer, Breast Cancer Female
on Oct 09, 2002 Female patient from NETHERLANDS , weighting 125.7 lb, was diagnosed with huntington's chorea, depression (What is depression?) and was treated with Riluzole (View Usage). After Riluzole was administered, patient had the following side effects: breast cancer (What is breast cancer?), breast cancer female. Riluzole dosage: . During the same period patient was treated with PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ). Patient was hospitalized.

4822536-1 | Constipation, Diarrhoea, Enteritis, Fatigue, Nausea, Weight Decreased
on Sep 25, 2002 Female patient from NETHERLANDS , weighting 83.78 lb, was diagnosed with huntington's chorea, constipation (What is constipation?), nausea (What is nausea?) and was treated with Riluzole (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), diarrhoea, enteritis, fatigue, nausea (What is nausea?), weight decreased. Riluzole dosage: . During the same period patient was treated with PSYLLIUM SEEDS (View Psyllium Seeds Review and Psyllium Seeds Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ). Patient was hospitalized.

4792416-9 | Dyspepsia, Nausea, Pruritus, Somnolence
Patient was taking Riluzole (View Usage). Patient had the following side effects: dyspepsia, nausea (What is nausea?), pruritus, somnolence on Sep 29, 2005 from Additional patient health information: Male patient , 54 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Riluzole dosage: . Patient was hospitalized.

4778467-9 | Hepatitis
Adverse event was reported on Sep 23, 2005 by a Male patient taking Riluzole (View Usage) (Dosage: 50 Mg Po Bid) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Location: UNITED STATES , 62 years of age, After Riluzole was administered, patient had the following side effects: hepatitis (What is hepatitis?).

4683686-6 | Apathy, Depression, Disturbance In Attention, Personality Change
on Jun 01, 2005 Female patient from , 50 years of age, was diagnosed with huntington's chorea, hypertension and was treated with Riluzole (View Usage). Patient experienced the following unwanted or unexpected effects: apathy, depression (What is depression?), disturbance in attention, personality change. Riluzole dosage: . During the same period patient was treated with TIAPRIDE (View Tiapride Review and Tiapride Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), EFFORTIL DEPOT (View Effortil-depot Review and Effortil-depot Label ). Patient was hospitalized.

4683679-9 | Depression, Suicidal Ideation
on Jun 01, 2005 Female patient from , 50 years of age, was diagnosed with huntington's chorea, depression (What is depression?), hypertension, psychotic disorder (What is psychotic disorder?) and was treated with Riluzole (View Usage). Patient had the following side effects: depression (What is depression?), suicidal ideation. Riluzole dosage: . During the same period patient was treated with TIAPRIDEX (View Tiapridex Review and Tiapridex Label ), CIPRAMIL (View Cipramil Review and Cipramil Label ), EFFORTIL (View Effortil Review and Effortil Label ), SOLIAN (View Solian Review and Solian Label ). Patient was hospitalized.

4673236-2 | Lymphocyte Count Decreased, Neutropenia
Patient was taking Riluzole (View Usage). After Riluzole was administered, patient had the following side effects: lymphocyte count decreased, neutropenia on May 09, 2005 from Additional patient health information: Female patient , 76 years of age, was diagnosed with motor neurone disease, glaucoma (What is glaucoma?) and. Riluzole dosage: . During the same period patient was treated with XALATAN (Dose: Unk) (View Xalatan Review and Xalatan Label ).